Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-21.04	62.29	78.88
Graham Fair Price	16.38	18.01	15.48
PEG	-82.67	0.80	-4.64
Price/Book	-5.60	11.78	12.48
Price/Cash Flow	-50.63	70.53	142.85
Prices/Earnings	-20.95	22.13	27.99
Price/Sales	-12.28	30.66	34.96
Price/FCF	-50.63	70.53	142.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	3.60	0.74	0.71
Operating Margin	12.19	0.45	0.40
ROA	17.49	0.04	0.03
ROE	0.11	0.13	19.42
ROIC	0.09	0.11	24.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	< 0.005	106.63
Dividends QOQ	< 0.005	< 0.005	-48.52
EBIT QOQ	-0.06	0.28	405.44
EPS QOQ	-0.06	0.28	356.09
FCF QOQ	-0.50	1.03	106.06
Revenue QOQ	-0.02	0.14	559.97
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1377.09	< 0.005	-100.00
Days Sales Outstanding (DSO)	118.11	106.43	-9.89
Inventory Turnover	0.07	379800000.00	581132595340.81
Debt/Capitalization	0.20	0.18	-9.18
Quick Ratio	0.42	0.43	3.31
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	9.78	10.41	6.50
Cash	3.88	4.92	26.95
Capex	-0.11	-0.13	-13.21
Free Cash Flow	0.85	1.74	103.62
Revenue	3.49	4.00	14.61
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.23	1.24	0.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.90	-1.25	-38.05
Naive Interpretation	Member

06 - Financial Health · Weak

Rating